TAQ
     RDKit          3D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -2.4301   -0.7390    0.0222 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6069   -1.4587   -0.1879 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3842    0.6424   -0.1216 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1739    1.3294    0.0449 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0452    0.6646    0.0924 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1892    1.3530    0.0713 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.3274    0.6581   -0.0207 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4904    1.3633   -0.0994 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4086   -0.6785   -0.0589 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.2592   -1.3610    0.0109 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0153   -0.7358    0.0983 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2229   -1.4146    0.1365 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3730   -2.7450    0.0548 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  2  0
  1 12  1  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  5 11  1  0
  6  7  2  0
  7  8  1  0
  7  9  1  0
  9 10  2  0
 10 11  1  0
 10 13  1  0
 11 12  2  0
M  END
>  <DRUGBANK_ID>  (1) 
DB02532

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
EXPT03006

>  <COMMON_NAME>  (1) 
2,4,6-Triaminoquinazoline

>  <UNII>  (1) 
WZD2M6Q8CC

$$$$
